Change of VO2 max and muscle mass after one-month and two-month upper and lower body exercises in stable chronic obstructive pulmonary disease
DOI:
https://doi.org/10.2478/AMB-2025-0058Keywords:
COPD, upper and lower body exercises, VO2 max, muscle massAbstract
Background: Skeletal muscle dysfunction inevitably occurs due to systemic inflammation of Chronic Obstructive Pulmonary Disease (COPD), which manifests as muscle atrophy and dysfunction. It also exhibits decreases in muscle strength and endurance, leading to a deconditioned state and a reduction in maximal oxygen uptake (VO2 max) in tissues. Exercise training can increase VO2 max value. The main purpose of this study is to evaluate the benefits and compare the effectiveness of upper and lower body exercises given for one to two months in stable COPD patients. Methods: This quasi-experimental study was conducted on 25 stable COPD patients from December 2018 to May 2019 at the Physiotherapy Unit of Siti Hajar Hospital, Medan, Indonesia. All participants performed upper-body exercises and stationary bicycles for lower-body exercises twice a week for one month, then continued for two additional months. VO2 max was calculated using the Nury Formula, specially developed for the Indonesian population, while muscle mass values were assessed using the OMRON Karada Scan scales. VO2 max and muscle mass were measured before training (baseline) after one-month and two-month training. The statistical analysis used is the Repeated ANOVA test. Results: The baseline of mean muscle mass in COPD patients was 28.8 ± 2.43%. Muscle mass increased to 29.1 ± 2.34% in one month and 29.5 ± 3.01% after two months (p < 0.05). The mean value of VO2 max before doing upper and lower body exercises was 21.0 ± 3.08%. VO2 was significantly increased after two-month training to 23.0 ± 3.6% (p < 0.001), but not after one-month training (VO2 max: 21.32 ± 3.22%; (p < 0.001). Conclusion: Two-month upper and lower body training provides a greater impact in improving VO2 max and muscle mass in stable COPD patients.
References
Hadfield R, Editor. Global Initiative for Chronic Obstructive Lung Disease: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. 2023 Ed. GOLD; 2023.
WHO. Smoking is the leading cause of chronic obstructive pulmonary disease [Internet]. WHO; 2023 [cited 2023 dec 20]. Available from: https://www.who.int/news/item/15-11-2023-smoking-is-the-leading-cause-of-chronic-obstructive-pulmonary-disease.
Amin M, Yunus F, Antariksa B, et al. PPOK Diagnosis dan Penatalaksanaan. Jakarta: Universitas Indonesia; 2016.
Maltais F, Decramer M, Casaburi R, et al. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189(9):15-62.
Gea J, Pascual S, Casadevall C, et al. Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings. J Thorac Dis. 2015;7(10):E418-E438.
Tarigan AP, Ananda FR. Exercise Training and Pulmonary Rehabilitation in COPD. Chronic Obstructive Pulmonary Disease – A Current Conspectus. IntechOpen; 2021. https://doi.org/10.5772/intechopen.97704
Abidin A, Yunus F, Wiyono W, Ratnawati, A. Manfaat Rehabilitasi Paru dalam Meningkatkan atau Mempertahankan Kapasitas Fungsional dan Kualitas Hidup Pasien Penyakit Paru Obstruktif Kronik di RSUP Persahabatan. Respirologi Indonesia. 2010.
Fukuchi Y. The Aging Lung and Chronic Obstructive Pulmonary Disease: Similarity and Difference. Proc Am Thorac Soc. 2009;6(7):570–2.
Kim HC, Mofarrahi M, Hussain SNA. Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. Int J ChronObstruct Pulmon Dis. 2008;3(4):637–58.
Rejbi IBC, Trabelsi Y, Chouchene A, et al. Changes in six-minute walking distance during pulmonary rehabilitation in patients with COPD and in healthy subjects. Int J Chron Obstruct Pulmon Dis. 2010;5:209-215.
Spruit MA, Burtin C, De Boever P, et al. COPD and exercise: does it make a difference? Breathe. 2016 Jun 4;12(2):e38–49.
Tarigan AP, Pandia P, Mutiara E, et al. Impact of Lower-Limb Endurance Training on Dyspnea and Lung Functions in Patients with COPD. Open Access Maced J Med Sci. 2018;6(12):2354-2358.
Tarigan AP, Ananda FR, Pandia P, et al. The Impact of Upper Limb Training with Breathing Maneuver in Lung Function, Functional Capacity, Dyspnea Scale, and Quality of Life in Patient with Stable Chronic Obstructive of Lung Disease. Open Access Maced J Med Sci. 2019;7(4):567–572.
Chen R, Chen R, Chen X, Chen L. Effect of endurance training on expiratory flow limitation and dynamic hyperinflation in patients with stable chronic obstructive pulmonary disease. Intern Med J. 2014;44(8):791–800.
Farias CC, Requeti V, Dias FA. Costs And Benefits of Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease: A Randomize Controlled Trial. Braz J Phys Ther 2014;18:165-173.
Kongsgaard M, Backer V, Jorgensen K, et al. Heavy resistance training increases muscle size, strength and physical function in elderly male COPD-patients – a pilot study. Respir Med 2004;98:1000-1007.
McKeough ZJ, Alison JA, Bye PT, et al. Exercise capacity and quadriceps muscle metabolism following training in subjects with COPD. Respir Med 2006; 100:1817-1825.
Man WD, Kemp P, Moxham J, Polkey MI. Exercise and muscle dysfunction in COPD: implications for pulmonary rehabilitation. Clin Sci (Lond). 2009;117(8):281-91.
Ortega F, Toral J, Cejudo P, et al. Comparison of Effects of Strength and Endurance Training in Patients with Chronic Obstructive Pulmonary Disease. 2002.
Leite MR, Ramos EMC, Kalva Filho CA, et al. Effects of 12 weeks of aerobic training on autonomic modulation, mucociliary clearence and aerobic parameters in patients with COPD. Int J Chron Obstruct Pulmo Dis. 2015; 10:2549-2557.
Scribbans TD, Vecsey S, Hankinson PB. The Effect of Training Intensity on VO2 Max in Young Healthy Adults. A Meta- Regression and Meta Analysis. International Journal Exercise Science. 2016:9(2), 230-247.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 A. P. Tarigan, M. Simatupang, Egipson, P. Pandia, A. Pradana, A. H. Tarigan, Maryaningsih, Zulkarnain, L. Agustin, P. Eyanoer (Author)

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to share, copy and redistribute the material in any medium or format under these terms.